Cochrane Abstracts
Different infusion durations for preventing platinum‐induced hearing loss in children with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Different Infusion Durations for Preventing Platinum‐induced Hearing Loss in Children With Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437227/all/Different_infusion_durations_for_preventing_platinum‐induced_hearing_loss_in_children_with_cancer.
Different infusion durations for preventing platinum‐induced hearing loss in children with cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437227/all/Different_infusion_durations_for_preventing_platinum‐induced_hearing_loss_in_children_with_cancer. Accessed March 19, 2025.
Different infusion durations for preventing platinum‐induced hearing loss in children with cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437227/all/Different_infusion_durations_for_preventing_platinum‐induced_hearing_loss_in_children_with_cancer
Different Infusion Durations for Preventing Platinum‐induced Hearing Loss in Children With Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437227/all/Different_infusion_durations_for_preventing_platinum‐induced_hearing_loss_in_children_with_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Different infusion durations for preventing platinum‐induced hearing loss in children with cancer
ID - 437227
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437227/all/Different_infusion_durations_for_preventing_platinum‐induced_hearing_loss_in_children_with_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
